Today’s stock pick update – Open Now

Learn More

Sponsored Retire On This One Little-Known Tech Stock Amazon, Apple and Tesla are proof you can retire on a single tech stock. But, those ships have sailed…making this little-known tech stock your top opportunity today. This company is funding the biggest ideas coming out of Silicon Valley in industries worth a combined $5 trillion, while paying out 90% of their venture capital gains to shareholders. Cash you can fund your retirement with as soon as possible, if you get in before their next big dividend payout. Click here for the full details Sponsored LinkThis Is The Top Tech Stock For 2022*

Biotechnology, X-ray, Biopharmaceuticals, Process Technology Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company’s lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythem... Read More SPX FLOW, Inc., together with its subsidiaries, designs, delivers, and services process technology solutions that perform mixing, blending, fluid handling, separation, thermal heat transfer, and other activities. Read More Don’t ignore the big discounts in Energy stocks like PSX That anticipation for increased demand early in the year – followed by indicators that confirmed demand for these activities was actually increasing – has pushed big increases in price for the commodity; from a starting point below $50 per barrel in January, for example West Texas Intermediate (WTI) crude is now sitting at around $70.50 per barrel. The increase is generally also being seen at the pump – which is generally good news for stocks in the Energy sector. One of the... Read More

Featured Stock Kezar Life Sciences, Inc. (KZR) – Buy Price: $15.00 or better Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company’s lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythem... Read More

Sponsored Weird, Anonymous Bets often followed by stock SURGES There’s never been a better time to join Ross Givens and a few thousand traders just like you as they quietly stalk the stock market in “stealth mode” Trading under-the-radar tickers that most investors will miss, all thanks to this one secret Ross learned working at one of the biggest investment banks in the world. Click here for your chance to leverage this unusual stock-picking GPS! Additional Sponsored Content WARNING: This New Tech Could Be Hidden On Your Phone   The $1 Billion Income Stock for 2022   Retire On This One Little-Known Tech Stock (up to $55,715/year) *(By clicking link you are subscribing to an Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy)

Already subscribed to our premium service? Click here to Login Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits Want More? Try the 5k Option Challenge - 5k into 60k in 12 months?  Option trading genius is profitable 11 of 12 months growing his account 650%. Need More Weekly Income? How To Generate Weekly Income From Home In 5 Minutes A Day Do You Have A Plan? FREE Trading Plan Checklist - Get Yours Now

This email was sent to indra21poetra@gmail.com from Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037 Unsubscribe Manage Emails Disclaimers, Terms & Conditions Privacy Policy Copyright 2021

Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.